Bioanalytical strategies to support a discovery research programme

Journal of Pharmaceutical and Biomedical Analysis

Volumn 14, Issue 8-10, 1996, Pages 1185-1190

  Rees, Susan A ^a  

^a Upjohn Laboratories Europe   (United Kingdom)

Author keywords

Bioanalysis; Discovery research; HPLC; Metabolism; Pharmacokinetics

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; SEROTONIN 1A AGONIST;

ACCURACY; ANIMAL EXPERIMENT; BLOOD BRAIN BARRIER; CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DETERMINATION; DRUG ISOLATION; DRUG RESEARCH; DRUG SCREENING; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0030176222     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(96)01764-5     Document Type: Conference Paper

References (5)

1. Arvidsson L.E., Hacksell U., Nilsson J.L.G., Hjorth S., Carlsson A., Lindberg P., Sanchez D., Wikstrom H. J. Med. Chem. 24:1981;921-923.
2. Wood S.A., Rees S.A., Simmonds R.J. J. Liq. Chromatogr. 15:1992;1227-1248.
3. Rees S.A., Wood S.A., Simmonds R.J. Reid E., Wilson I.D. Bioanalytical Approaches for Drugs, Including Anti-asthmatics and Metabolites. Methodological Surveys in Biochemistry and Analysis. 22:1992;65-70 Royal Society of Chemistry, Cambridge.
4. Seglen P.O. Exp. Cell Res. 82:1973;391-398.
5. Seglen P.O. Methods Cell Biol. 13:1976;29-83.